Ezetimibe Induces Vasodilation in Rat Mesenteric Resistance Arteries through Inhibition of Extracellular Ca2+ Influx

Ezetimibe is a lipid-lowering agent that selectively inhibits cholesterol absorption by binding to the Niemann–Pick C1-like 1 (NPC1L1) protein. Although it is well known that administration of ezetimibe in hypercholesterolemia patients reduces the risk of cardiovascular events through attenuation of...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	International journal of molecular sciences 2023-09, Vol.24 (18), p.13992
Hauptverfasser:	Oh, Eun Yi, Haam, Chae Eun, Choi, Sooyeon, Byeon, Seonhee, Choi, Soo-Kyoung, Lee, Young-Ho
Format:	Artikel
Sprache:	eng
Schlagworte:	Atherosclerosis Cardiovascular disease Cholesterol Coronary vessels Endothelium Fatalities Heart Kinases Mortality Nitric oxide Phosphorylation Plasma Smooth muscle Statins Vein & artery diseases
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!